LPG-150 Centrifugal Spray Drying Machine for Pharmaceuticals

Name: LPG-150 Centrifugal Spray Drying Machine for Pharmaceuticals
Brand: Shanghai Pharmaceutical Machinery Co., Ltd.
SKU: 772177355

Shanghai, ChinaShanghai Pharmaceutical Machinery Co., Ltd.

US$1.00-80,000.00

1 Set

Product profile

Certification

CE, GMP, ISO

Condition

New

Customized

Non-Customized

Model NO.

LPG-150

Voltage

According to Your Requirement

Inter Temperature(C)

140~300

Outer Temperature (C)

70~90

Evaporated Amount of Moisture (Kg/H)

150

Revolution (Rpm)

15500

Diameter of Atomizing Disc (mm)

150

Type

Preparation Machinery

Precision

High Precision

Computerized

Warranty

1 Year

Finished Dosage Form

Powder

Transport Package

Seaworthy

Specification

GMP

Trademark

SPM

Origin

Shanghai

HS Code

8419399090

Production Capacity

150kg

Company profile

Experienced TeamExhibition ExperienceImporters and ExportersLow MOQ

Shanghai Pharmaceutical Machinery Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤6.44h CertifiedTerms of Payment: T/T, LC, PayPal, etc.

AI-Powered supplier vetting

SummaryThe supplier is identified as a Shanghai-based combined trading company with listed pharmaceutical equipment products and machining-related facilities. It reports extensive customization, R&D activity with new products in the past year, export experience of 20 years, and exports representing 90% of total sales. After-sales support includes repair services and overseas agents or branches, but no overseas warehouse or showroom. Finished-product inspection instructions are reportedly available and uniformly followed. The supplier does not provide ODM services, lacks an available SDK, and does not provide OEM services for well-known brands. Evidence is insufficient to verify certifications, detailed financial credibility, production scale, or named customer cases.

After-Sales capabilityThe supplier reports repair as an overseas service offering and states that it can provide services through overseas agents or branches. However, it has no overseas warehouse or showroom, so the evidence supports some service access but not comprehensive overseas infrastructure.

R&D capabilityThe supplier reports R&D capability and states that it launched new products during the past year. It does not have an available SDK and does not provide ODM services, but these limitations do not negate the explicit evidence of recent product development.

Production capacityThe supplier lists machining centers, CNC and milling equipment, provides a broad pharmaceutical-equipment product range, and reports a finished-product inspection method with instructions that are uniformly followed. However, the supplied data does not quantify production capacity, output, or manufacturing ownership, so production strength is only partially evidenced.

Customization capabilityBoth R&D and design-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization offering.